Patents
Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291)
06/2010
06/10/2010US20100143242 Delivery system for therapy comprising hollow seeds, and the method of use thereof
06/10/2010US20100143241 Method and apparatus for delivery of agents across the blood brain barrier
06/10/2010US20100140483 Radioimaging applications of and novel formulations of teboroxime
06/10/2010CA2745958A1 Ca-ix specific radiopharmaceuticals for the treatment and imaging of cancer
06/10/2010CA2745955A1 Technetium- and rhenium- bis (heteroaryl) complexes and methods of use thereof for inhibiting psma
06/10/2010CA2745923A1 Sparc binding scfvs
06/10/2010CA2745918A1 Technetium- and rhenium-bis(heteroaryl) complexes and methods of use thereof
06/10/2010CA2745899A1 Albumin binding peptide-mediated disease targeting
06/10/2010CA2745495A1 Nitrogen-containing macrocyclic conjugates as radiopharmaceuticals
06/09/2010EP2193115A1 Compound, diagnostic agent, nuclear magnetic resonance analysis method, nuclear magnetic resonance imaging method, mass spectrometry method and mass spectrometry imaging method
06/09/2010EP2192928A2 Perfluoro-aryliodonium salts in nucleophilic aromatic 18f-fluorination
06/09/2010CN101723850A Novel 18F labeled aromatic amino acids, preparation method and application thereof in tumor imaging
06/09/2010CN101723849A Novel 18F labeled amino acid derivatives, preparation method and application thereof in tumor imaging
06/09/2010CN101723848A Novel 18F labeled m-nitro benzoyl amino acids, preparation method and application thereof in tumor imaging
06/09/2010CN101723847A Novel 18F labeled p-nitro benzoyl amino acid compound and preparation method and application thereof
06/09/2010CN101723846A Novel 18F labeled p-nitro benzoyl amino acid derivatives, preparation method and application thereof in tumor imaging
06/09/2010CN101721720A Nitroimidazole-amino acid compound nuclide hypoxic contrast agent and precursor thereof
06/08/2010US7734331 Systems, methods and apparatus for preparation, delivery and monitoring of radioisotopes in positron emission tomography
06/08/2010US7732159 Using plasminogin activator concentration as indicator of tumor progress and antitumor drug efficacy
06/08/2010US7731995 Methods for using soy peptides to inhibit H3 acetylation, reduce expression of HMG CoA reductase, and increase LDL receptor and Sp1 expression in a mammal
06/08/2010US7731979 Protective antigen having fluorinated histidine residues
06/08/2010US7731936 metabolically stable metal complexes that are suitable for conjugation with biomolecules and radiology
06/08/2010CA2458946C Composite staple for completing an anastomosis
06/08/2010CA2389300C 4-phenyl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine and serotonin
06/03/2010WO2010060217A1 Antibody-targeted carrier for contrast agents
06/03/2010WO2010013139A3 Radionuclide-labeled erlotinib
06/03/2010US20100137365 Long chain N-alkyl compounds and oxa-derivatives thereof
06/03/2010US20100136626 Production and Use of Novel Peptide-Based Agents for Use with Bi-Specific Antibodies
06/03/2010US20100135906 In vivo imaging of sulfotransferases
06/03/2010US20100135905 Assessment of cancer susceptibility to molecular targeted therapy by use of recombinant peptides
06/03/2010US20100135904 Compositions and methods for the inhibition of cripto / grp78 complex formation and signaling
06/03/2010US20100135903 Use of a dna damaging agent and a ligand for the treatment of cancer
06/03/2010US20100135902 Papillomavirus pseudoviruses for detection and therapy of tumors
06/03/2010US20100135901 Combination therapy
06/03/2010US20100135900 Cd37 immunotherapeutic combination therapies and uses thereof
06/03/2010CA2744344A1 Antibody-targeted carrier for contrast agents
06/02/2010EP2190990A1 Pthrp, its isoforms and antagonist thereto in the diagnosis and treatment of disease
06/02/2010EP2190880A1 Cytotoxicity mediation of cells evidencing surface expression of cd9
06/02/2010EP2190484A2 Improved radiopharmaceutical composition
06/02/2010EP1438299B1 Bifunctional chelating agent for actinium
06/02/2010CN101716353A Folic acid composite used for imageology diagnosis of tumor and lymphatic metastasis tumor
06/01/2010US7728104 Process for preparing glycopeptide phosphonate derivatives
06/01/2010US7727957 Treatment and delay of outset of Parkinson's disease
06/01/2010US7727525 Engineered anti-CD20 antibody fragments for in vivo targeting and therapeutics
06/01/2010US7727512 Nanoparticle emulsion in perfluorohydrocarbon solvent; chelating agents coupled, optionally through a spacer, to phosphoglyceride; magnetic resonance imaging; excretion of toxic paramagnetic ion
06/01/2010US7727511 Agents for imaging soluble a-beta
06/01/2010CA2440680C Steroids as agonists for fxr
06/01/2010CA2370666C A tenascin-c isoform as a marker for neoplasias
06/01/2010CA2256592C Improved methods for diagnostic imaging by regulating the administration rate of a contrast agent
06/01/2010CA2219961C Vasopermeability enhancing peptide of human interleukin-2 and immunoconjugates thereof
05/2010
05/27/2010WO2010060104A2 Implantable liposome embedded matrix composition, uses thereof, and polycaprolactone praticles as scaffolds for tissue regeneration
05/27/2010WO2010059905A2 Imaging ligands
05/27/2010WO2010058361A2 Method for the production of scaffolds for tissue engineering, comprising the use of an anchoring unit, and scaffold produced therewith
05/27/2010US20100129290 Smart contrast agent and detection method for detecting transition metal ions
05/27/2010US20100129289 Compositions and methods for the detection of vulnerable plaque
05/27/2010US20100129288 Gliomedin, Fragments Thereof and Methods of Using Same
05/26/2010EP2187803A1 Multimodality agents for tumor imaging and therapy
05/26/2010EP1867634B1 Ligand for vesicular acetylcholine transporter
05/26/2010EP1718737B1 Cancerous disease modifying antibodies
05/26/2010EP1272665B1 Compositions and methods for identifying and targeting cancer cells of alimentary canal origin
05/26/2010CN1912111B Engomphosis and radiolabeled antibodies to human b lymphocyte restricted differentiation antigen
05/26/2010CN1829735B Imaging agents
05/26/2010CN1771058B Microwave method for preparing radiolabelled gallium complexes
05/26/2010CN1665933B Immunoconjugates for the treatment of tumours
05/26/2010CN1642580B Radiolabelled quinoline and quinolinone derivatives and their use as metabotropic glutamate receptor ligands
05/26/2010CN1638807B Avidin dimers effective in increasing the concentration of radioactive biotin in pretargeted radioimmunotherapy
05/26/2010CN101712721A T cell receptor fusions and conjugates and methods of use thereof
05/25/2010US7723305 Abuse-resistant amphetamine prodrugs
05/25/2010US7723049 Marker for inflammatory conditions
05/25/2010US7722857 one or more kinds of immunostimulating substances carried separately by two or more kinds of microparticle immunostimulating substance carriers and comprising a combination of inorganic substance such as microparticle calcium phosphate and precipitates of soluble protein and mucopolysaccharide; antitumor
05/25/2010US7722855 Extracellular vesicles from non-pathogenic amoebae useful as vehicle for transferring a molecule of interest to an eukaryotic cell
05/25/2010CA2361573C Biodegradable glass compositions and methods for radiation therapy
05/20/2010WO2010009220A3 Radiolabelled trp m8 receptor ligands
05/20/2010CA2743464A1 Therapeutic and diagnostic methods relating to cancer stem cells
05/20/2010CA2743282A1 Simultaneous measurment of the in vivo metabolism of isoforms of a biomolecule
05/19/2010EP2186508A2 Methods and unit dose formulations for the inhalation administration of aminoglycoside antibiotics
05/19/2010EP2185933A2 Matriptase protein and uses thereof
05/19/2010EP0907735B9 Modulators of tissue regeneration
05/19/2010CN101709060A F-triazole ring-polyethylene glycol-metronidazole compound and preparation method thereof
05/18/2010US7718777 MHC-peptide complex binding ligands
05/18/2010US7718619 Abuse-resistant amphetamine prodrugs
05/18/2010US7718617 Using tissue preservation solution ( kallikrein inhibitor ) to decrease reperfusion injury of an organ during surgery and/or following removal of organ
05/18/2010US7718599 Peptides present in form of acetate, gluconate, glucuronate, lactate, citrate, ascorbate, benzoate or phosphate salts and administration forms also contain one of above acids as free acids; for treating sex hormone-dependent diseases
05/18/2010US7718161 Method for treating a motoneuron disorder
05/18/2010US7718160 Radiolabeled compounds and liposomes and their method of making and using same
05/14/2010WO2010052143A1 Radiolabelled inhibitors of the glycine 1 transporter
05/14/2010CA2742515A1 Modulators of cxcr7
05/13/2010US20100121184 Systems, methods and apparatus for preparation, delivery and monitoring of radioisotopes in positron emission tomography
05/13/2010US20100120688 ErbB Interface Peptidomimetics And Methods Of Use Thereof
05/13/2010US20100119448 Method for production of radiation diagnostic imaging agent
05/13/2010US20100119447 Radiolabeled lymphatic staining agents and methods for making
05/13/2010US20100119446 Specific and high affinity binding proteins comprising modified sh3 domains of fyn kinase
05/13/2010US20100119445 Plexin d1 as a target for tumor diagnosis and therapy
05/13/2010US20100119444 Tumor-Targeting Peptides and Uses Thereof
05/13/2010US20100119443 Radiotherapeutic system and method performed by non-invasive and real-time tumor position tracking
05/12/2010EP2183275A1 Igf-1r binding polypeptides and their use
05/12/2010EP2183272A2 Radiolabeled monomeric and multimeric cyclic oligopeptides binding to the cxcr4 receptor for cancer imaging and treatment
05/12/2010EP2182988A2 Radiopharmaceutical composition
05/12/2010EP2182956A2 Salicylanilide modified peptides for use as oral therapeutics
05/12/2010CN1867363B Mechanism-based targeted pancreatic beta cell imaging and therapy
1 ... 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 ... 243